Useful Links

ToleroTech is an emerging siRNA company focusing on treatment of immune-associated diseases through immunomodulation using gene-specific silencing technologies. ToleroTech dedicates to developing novel siRNA solutions, drugs, and vaccines for curing cancer, autoimmune diseases, allergic diseases and transplant rejection. Based on our 5-year research and 6 filed patents, ToleroTech have been developing 6 drugable siRNA product pipelines. ToleroTech is seeking for investors and partners to launch siRNA products to market.